As part of the BayBIO series on personalized medicine, Dr. Moira Gunn speaks with Jeff Peterson, CEO of Target Discovery, Inc. They discuss measuring tiny isoforms that exist within proteins - a capability that offers much to people suffering from prostate and ovarian cancer.

On the Bio-Issue of the Week, Dr. Gunn and David Ewing Duncan discuss what brain scans can tell us about the human desire to be charitable.